UNSPSC 85642221: Replacement of left hand subcutaneous tissue and fascia with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of left hand subcutaneous tissue and fascia with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0JRK37Z

UNSPSC 85642221 Replacement of left hand subcutaneous tissue and fascia with autologous tissue substitute, percutaneous approach is a Commodity code that shows little relevant recent activity in state and local government procurement. The code's nominal scope—a specific surgical procedure code drawn from medical taxonomy—does not align with the work actually being solicited under this code designation in recent opportunities. The most recent activity tagged to this code encompasses independent medical evaluation services, occupational medical surveillance, pharmacy benefit management, temporary health professional staffing, and surgical carve-out benefit programs—none of which involve the procedure named in the code itself.

The issuing bodies soliciting under this code include city retirement offices, state transportation departments, county health systems, county probation departments, and county boards of commissioners across Arizona, California, Florida, and Washington. Representative recent opportunities include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (due October 16, 2026) supporting disability benefit determinations for public safety personnel, the Washington State Department of Transportation's RFP for occupational medical surveillance services across 14 Washington State Ferries locations (due October 9, 2026), and the County of Santa Clara Health System's solicitation for temporary health professional staffing across 13 ancillary clinical categories (due October 7, 2026). The code's use in procurement tagging appears to be a classification mismatch rather than a signal of active procurement demand for the specific procedure; buyers and analysts should verify actual scope requirements before pursuing.